Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Safe and effective if used under the supervision of a qualified doctor
2003, 63 (special issue 2): 5-13
A first-in-human, randomized, double-blind, single- and multiple-dose, phase I study of recombinant human thymosin beta4 in healthy Chinese volunteers. Journal of Cellular and Molecular Medicine
The inhibition is competitive glutathione competes with tyrosine (the amino acid tyrosinase acts on) for enzyme binding sites which is why the relationship between dosing, delivery method, and effect is not linear
US$ 22.49
US$ 21.09
US$ 22.67
US$ 24.82
